Compare CMRC & CNXU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CMRC | CNXU |
|---|---|---|
| Founded | 2009 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Industrial Specialties |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 183.9M | 215.9M |
| IPO Year | 2020 | 2025 |
| Metric | CMRC | CNXU |
|---|---|---|
| Price | $2.20 | $7.97 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $4.88 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 124.1K |
| Earning Date | 05-07-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.43 | N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $342,349,000.00 | N/A |
| Revenue This Year | $5.11 | N/A |
| Revenue Next Year | $4.50 | N/A |
| P/E Ratio | $37.00 | ★ N/A |
| Revenue Growth | ★ 2.83 | N/A |
| 52 Week Low | $1.95 | $6.85 |
| 52 Week High | $5.55 | $13.66 |
| Indicator | CMRC | CNXU |
|---|---|---|
| Relative Strength Index (RSI) | 35.54 | 43.51 |
| Support Level | $1.95 | $7.55 |
| Resistance Level | $3.16 | $10.35 |
| Average True Range (ATR) | 0.19 | 1.14 |
| MACD | -0.11 | -0.00 |
| Stochastic Oscillator | 16.61 | 33.43 |
Commerce.com Inc is engaged in offering a Software-as-a-Service (SaaS) e-commerce platform. The company's SaaS platform engages in the creation of online stores by delivering a combination of ease-of-use, enterprise functionality, and flexibility. It powers both the customers' branded ecommerce stores and their cross-channel connections to popular online marketplaces, social networks, and offline point-of-sale systems. The group operates in a single segment covering geographical areas of Americas-U.S.; Americas-other; EMEA; and APAC, of which the majority of its revenue is generated from Americas-U.S.
Conexeu Sciences Inc is an early-stage medical technology company. The company develops and supplies collagen-based technologies that helps doctors and patients regenerate tissue naturally, safely, and effectively. The company is focused on developing regenerative biomaterials that address relative needs in wound care, dentistry, and aesthetics. The company seek to provide physicians with device-based solutions that improve healing, restore soft tissue, and enhance patient outcomes across multiple clinical settings. The company focuses durable, and growing addressable markets in regenerative aesthetics, wound care, 3D-printed tissue structures, veterinary wound repair, and dental soft-tissue regeneration.